| Serial Number | 90858111 |
| Word Mark | PROTEOVANT |
| Filing Date | Friday, July 30, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 1, 2023 |
| Registration Number | 7123854 |
| Registration Date | Tuesday, August 1, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 16, 2023 |
| Goods and Services | Pharmaceutical preparations for human use comprising small molecules for degrading disease-causing cellular proteins for prevention and treatment of oncological, allergy and immunological, neurological, cardiac, dermatological, endocrinological, gastroenterological, hematological, infectious, genetic, nephrological, gynecological, ophthalmological, orthopedic, otorhinolaryngological, podiatric, psychiatric, pulmonological, respiratory, rheumatological, and urological diseases and disorders; biologic preparations for medical and therapeutic purposes comprising small molecules for degrading disease-causing cellular proteins for prevention and treatment of oncological, allergy and immunological, neurological, cardiac, dermatological, endocrinological, gastroenterological, hematological, infectious, genetic, nephrological, gynecological, ophthalmological, orthopedic, otorhinolaryngological, podiatric, psychiatric, pulmonological, respiratory, rheumatological, and urological diseases and disorders; pharmaceutical and biological preparations for treatment and prevention of cancer and for the treatment and prevention of auto-immune diseases and disorders and central nervous system and neurological diseases and disorders |
| Goods and Services | Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions |
| Goods and Services | Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology; scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 27, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 27, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 27, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Roivant Sciences GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Party Name | Roivant Sciences GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Party Name | Roivant Sciences GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Event Date | Event Description |
| Tuesday, August 1, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 1, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 16, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 16, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 26, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 12, 2023 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, April 7, 2023 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Monday, April 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 17, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 17, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 17, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, February 28, 2023 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED |
| Tuesday, February 28, 2023 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED |
| Tuesday, February 28, 2023 | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED |
| Wednesday, February 15, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 14, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, November 29, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, November 29, 2022 | FINAL REFUSAL E-MAILED |
| Tuesday, November 29, 2022 | FINAL REFUSAL WRITTEN |
| Friday, October 28, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 27, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 27, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 27, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 27, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, April 27, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 27, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, October 5, 2021 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Monday, October 4, 2021 | ASSIGNED TO LIE |
| Wednesday, August 4, 2021 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Monday, September 27, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 3, 2021 | NEW APPLICATION ENTERED |